Source: Annual Congress 2013 –Significance of intestinal and respiratory tract cross-talk in chronic lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Taube (Leiden, Netherlands). H.p. is good for you: protective effects of helicobacter infections in airway disease. Annual Congress 2013 –Significance of intestinal and respiratory tract cross-talk in chronic lung diseases

Member's Comments

No comment yet.

Related content which might interest you: Macrolides, inflammation and the lung microbiome: cause or effect? Source: International Congress 2018 – State of the art session: Airways disease Year: 2018 Bacterial infection and COPD - cause or effect? Source: International Congress 2018 – PG9 Chronic obstructive pulmonary disease exacerbations Year: 2018 How important is work as a risk for lung infections? A story of tuberculosis and pneumonia Source: Virtual Congress 2020 – How much lung disease is really caused by work, and how to assess the worker who wishes to continue working? Year: 2020 Antifungals in pulmonary infections: to whom, when and how? Source: Eur Respir Monogr 2017; 75: 159-184 Year: 2017 Probiotics: promise or failure to influence airway disease Source: Annual Congress 2013 –Significance of intestinal and respiratory tract cross-talk in chronic lung diseases Year: 2013 Opportunist mycobacterial lung disease - which drug combination is more effective? Source: Breathe 2009; 6: 67-69 Year: 2009 Bronchial inflammation, respiratory symptoms and lung function in patients who finished treatment for pulmonary tuberculosis: is it the beginning of a new disease? Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Does mucus protect or lead to epithelial colonisation and infection? Source: Annual Congress 2011 - Mucus in airway diseases: bad or good partner? Year: 2011 How contagious are the new viruses and how can you protect yourself? Source: Annual Congress 2005 - Major viral threats to the lung Year: 2005 What is bacterial colonisation in COPD? Source: Eur Respir Monogr 2015; 69: 161-171 Year: 2015 Side effects of tuberculosis chemotherapy: intestinal dysbiosis Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020 Infection: friend or foe in the development of atopy and asthma? The epidemiological evidence Source: Eur Respir J 2001; 18: 872-881 Year: 2001 The effect of chlamydia pneumoniae infection on the course of bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 516s Year: 2003 What can we learn about pulmonary infection from studying the microbiome in CF? Source: International Congress 2016 – What can respiratory medicine learn from cystic fibrosis research? Year: 2016 Are there risk factors that may influence use of antibiotics in viral lower respiratory tract infections in children? Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008 Helicobacter pylori – infection status, childhood living conditions and signs of allergic diseases in an occupational population – a hygiene hypothesis supporting model Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease Year: 2007 Impact of bacterial infections on airway diseases Source: Eur Respir Rev 2005; 14: 62-68 Year: 2005 Is it just an infection? Source: Breathe, 14 (3) e100; 10.1183/20734735.021518 Year: 2018 Hyperergic reactions on Helicobacter pylori infection in patients with asthma contributes to stomach mucosa damage Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007